Terms & conditions
Terms & conditions
This website is designed in the United Kingdom and is for information purposes only and is not an advertisement. Nothing on this site constitutes a binding offer to perform any service.
Although we have taken care over what is said in this website, any advice contained in the website is of a generic nature only. Any reliance by you on such advice or any information in the site is entirely at your own risk and we do not accept any liability to any person who relies on it.
We are not responsible for the content of any other site (website, blog, social media or other), including any site through which you may have gained access to this website or to which you may gain access from this website. We do not accept any liability in connection with any such sites or links.
Copyright
You are responsible for obeying all applicable copyright laws. We permit you to make copies of this site as necessary incidental acts during your viewing of it; and you may take a print for your personal use of so much of the site as is reasonable for private purposes, but you must not otherwise copy it, use it or re-publish it in whole or in part (including by linking or framing) without this “Disclaimer” section nor without first obtaining written consent from I C Consultants Ltd.
© I C Consultants Ltd. All rights reserved, and all moral rights are asserted and reserved.
Latest news, insights and events
Global methane emissions rising at alarming rate
Our analysis shows that increased human activities are the most likely cause advises Dr Apostolos Voulgarakis. The Global Methane Budget charts the sources and sinks of global methane from our atmosphere. Its 2016 update shows that methane in the atmosphere has increased by 150 percent since the year 1750, and is responsible for 20 percent of the global warming produced by all greenhouse gases so far. read more
Imperial Consultants contribute to novel pain drug success
Australian pharmaceutical company, Spinifex Pharmaceuticals (“Spinifex”) has recently presented the clinical development of their lead product at the 14th World Congress of Pain®, highlighting the success of consultancy through Imperial Consultants. read more
Robotic testing platform helps to scale up COVID-19 testing capacity
Imperial team has repurposed robotic technology normally used for synthetic biology research to help with testing for COVID-19. read more